• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Function-structure relationship; role of the islet Schwann cells

Research Project

Project/Area Number 26461346
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Metabolomics
Research InstitutionJikei University School of Medicine

Principal Investigator

Sasaki Takashi  東京慈恵会医科大学, 医学部, 教授 (90205849)

Co-Investigator(Kenkyū-buntansha) 藤本 啓  東京慈恵会医科大学, 医学部, 准教授 (40372974)
Research Collaborator Nemoto Masami  
Kouno Midori  
Yoshizawa Yukio  
Project Period (FY) 2014-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Keywords膵島障害 / インスリノーマ / 三次元培養法 / インスリン分泌 / ブドウ糖応答性 / 自己組織化 / 恒常性の破綻 / 膵島三次元構造 / Schwann細胞 / ブドウ糖応答性インスリン分泌 / gap junction / ゲノム編集 / 酸化ストレス / 神経堤 / シュワン細胞 / インスリン / 培養 / pancreatic islet
Outline of Final Research Achievements

In this study, with the aim of basic research to understand the mechanism of exhaustion of islet function that causes diabetes, we analyzed the interaction between cultured Schwann cells and cultured murine β cells as well as cells isolated from human insulinoma tissue. We focus on what kind of cells consisting the microenvironment of the islet, and whether the cells have antioxidant ability to defense from the oxidative stress that causes the dysfunction, and gene mutations that affect secretory ability. For these purpose, we analyzed the influence of oxidative stress on the cells of pancreatic islets by cultured cell lines, identification of a signal transduction system between intra-islet cells within a three-dimensional culture system, and gene mutation of human pancreatic insulinoma cells. We found that the mechanism of coordination in the islet microenvironment as well as the involvement of specific genes have been estimated.

Academic Significance and Societal Importance of the Research Achievements

酸化ストレスや特定の遺伝子異常による膵内分泌機能、すなわちブドウ糖応答性インスリン分泌機能の低下は糖尿病の原因と考えられている。本研究ではその発生メカニズムを明らかにする上で、特に膵島の三次元的な構成と機能の連関、構成細胞として膵島を被覆するシュワン細胞をも考慮に入れた点がユニークな研究であった。また、低重力培養装置を用いた三次元培養法による細胞間の相互作用の検討、ならびにヒトインスリノーマ細胞におけるインスリン分泌異常を起こす遺伝子異常に焦点を当てた点は、方法論としても新規のもので、当該分野に与えるインパクトも大きい。

Report

(6 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • 2015 Research-status Report
  • 2014 Research-status Report
  • Research Products

    (23 results)

All 2018 2017 2016 2015 2014

All Journal Article (13 results) (of which Peer Reviewed: 10 results,  Open Access: 8 results) Presentation (10 results) (of which Int'l Joint Research: 1 results,  Invited: 2 results)

  • [Journal Article] Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study.2018

    • Author(s)
      Takashi Sasaki, Sugawara M, Fukuda M.
    • Journal Title

      J Diabetes Investig

      Volume: 10

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment.2018

    • Author(s)
      Samukawa Y, Haneda M, Seino Y, Sasaki T. Fukatsu A, Kubo Y, Sato Y, Sakai S.
    • Journal Title

      Clin Pharmacol Drug Dev

      Volume: 7 Issue: 8 Pages: 820-828

    • DOI

      10.1002/cpdd.456

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Sarcopenia, frailty circle and treatment with sodium-glucose cotransporter 2 inhibitors.2018

    • Author(s)
      Takashi Sasaki
    • Journal Title

      J Diabetes Investig

      Volume: 10 Issue: 2 Pages: 193-195

    • DOI

      10.1111/jdi.12966

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period.2018

    • Author(s)
      Seino Y, Sasaki T, Fukatsu A, Imazeki H, Ochiai H, Sakai S.
    • Journal Title

      Curr Med Res Opin

      Volume: 34 Issue: 6 Pages: 981-994

    • DOI

      10.1080/03007995.2018.1441816

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study.2018

    • Author(s)
      Seino Y, Yabe D, Sasaki T, Fukatsu A, Imazeki H, Ochiai H, Sakai S.
    • Journal Title

      J Diabetes Investig.

      Volume: 9 Issue: 2 Pages: 338-340

    • DOI

      10.1111/jdi.12694

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] SGLT2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT Study with Luseogliflozin.2018

    • Author(s)
      Sasaki T, Sugawara M, Fukuda M.
    • Journal Title

      J Diabetes Investig.

      Volume: 9 Issue: 1 Pages: 108-117

    • DOI

      10.1111/jdi.12851

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Modified Western blotting for insulin and other diabetes-associated peptide hormones.2017

    • Author(s)
      Okita N, Higami Y, Fukai F, Kobayashi M, Mitarai M, Sekiya T, Sasaki T.
    • Journal Title

      Sci Rep

      Volume: 7:6949 Issue: 1 Pages: 1-11

    • DOI

      10.1038/s41598-017-04456-4

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] SGLT2阻害薬によるケトン体の上昇の意味は? 心血管イベントのリスク減少機序としては、高ケトンよりも血圧低下、体液減少、交感神経の過緊張の解除が有力2017

    • Author(s)
      佐々木 敬
    • Journal Title

      日本医事新報

      Volume: 4882 Pages: 62-63

    • Related Report
      2017 Research-status Report
  • [Journal Article] SGLT2阻害薬ルセオグリフロジンの高齢2型糖尿病患者における安全性と有効性の検討 高齢者における特定使用成績調査(最終報告)2017

    • Author(s)
      黒瀬 健, 稲垣暢也, 深津敦司, 佐々木 敬, 北島壮一, 清野 裕
    • Journal Title

      薬理と治療

      Volume: 45 Pages: 559-569

    • Related Report
      2017 Research-status Report
  • [Journal Article] 日本人2型糖尿病患者に対するSGLT2阻害薬ルセオグリフロジンの増量効果の検討 国内第III相52週投与試験の併合解析2017

    • Author(s)
      佐々木 敬, 玉置 浩之, 坂井 荘一, 寒川 能成
    • Journal Title

      Progress in Medicine

      Volume: 37 Pages: 769-776

    • Related Report
      2017 Research-status Report
  • [Journal Article] Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials2016

    • Author(s)
      Soichi Sakai, Kohei Kaku, Yutaka Seino, Nobuya Inagaki, Masakazu Haneda, Takashi Sasaki, Atsushi Fukatsu, Haruka Kakiuchi, Yoshishige Samukawa
    • Journal Title

      Clinical Therapeutics

      Volume: 38 Issue: 4 Pages: 843-862

    • DOI

      10.1016/j.clinthera.2016.01.017

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] High-throughput screening of small interfering ribonucleic acid identifies important modulators in islet dysfunction and apoptosis.2015

    • Author(s)
      Masami Nemoto, Takashi Sasaki
    • Journal Title

      Journal of Diabetes Investigation

      Volume: 6 Issue: 4 Pages: 390-392

    • DOI

      10.1111/jdi.12283

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Epigenetics: Reprogrammable interface of the genome and environments.2014

    • Author(s)
      Takashi Sasaki
    • Journal Title

      Journal of Diabetes Investigation

      Volume: 5 Issue: 2 Pages: 119-120

    • DOI

      10.1111/jdi.12150

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 日本人1型糖尿病家系における非HLA遺伝子の連鎖と両親からの遺伝様式の検討2017

    • Author(s)
      根本昌実, 溝渕杏子, 佐々木 敬, 藤本 啓, 比企能人, 大橋十也, 宇都宮一典
    • Organizer
      第21回日本適応医学会学術集会(12月、東京)
    • Related Report
      2017 Research-status Report
  • [Presentation] Western blottingのプロトコール改変によるinsulin及び糖尿病関連ペプチドホルモンの定量検出の実現2017

    • Author(s)
      沖田直之, 樋上賀一, 深井文雄, 小林正樹, 御手洗光来, 関谷剛男, 佐々木 敬
    • Organizer
      第60回日本日本糖尿病学会学術集会(5月、名古屋)
    • Related Report
      2017 Research-status Report
  • [Presentation] SGLT2阻害薬ルセオグリフロジンの長期使用における安全性と有用性の検討 長期使用に関する特定使用成績調査(中間報告)2017

    • Author(s)
      黒瀬 健, 稲垣暢也, 深津敦司, 佐々木 敬, 笠井良樹, 北島壮一, 清野 裕
    • Organizer
      第60回日本日本糖尿病学会学術集会(5月、名古屋)
    • Related Report
      2017 Research-status Report
  • [Presentation] SGLT2阻害薬による治療に伴う体組成の変化と代謝の連関 52週間の前向き研究LIGHT Study2017

    • Author(s)
      佐々木 敬, 菅原正弘, 福田正博
    • Organizer
      第60回日本日本糖尿病学会学術集会(5月、名古屋)
    • Related Report
      2017 Research-status Report
  • [Presentation] リラグルチド単独で血糖コントロール不十分な2型糖尿病患者へのルセオグリフロジン追加投与時の長期安全性・有効性に関する検討2017

    • Author(s)
      矢部大介, 佐々木 敬, 深津敦司, 今関寿恵, 落合秀和, 坂井荘一, 清野 裕
    • Organizer
      第60回日本日本糖尿病学会学術集会(5月、名古屋)
    • Related Report
      2017 Research-status Report
  • [Presentation] 健常者における麦飯と主菜の併用による食後血糖上昇の検討2017

    • Author(s)
      小川篤美, 石崎知子, 細田暁彦, 種村陽子, 篠田良行, 赤石定典, 湯浅 愛, 小沼宗大, 濱 裕宣, 佐々木 敬, 吉田 博
    • Organizer
      第12回日本機能性食品医用学会総会(12月、京都)
    • Related Report
      2017 Research-status Report
  • [Presentation] 健常者における麦飯と主菜の併用による食後血糖上昇の検討2017

    • Author(s)
      杉原聡子, 石崎知子, 早乙女 恵, 細田暁彦, 種村陽子, 篠田良行, 小川篤美, 赤石定典, 湯浅 愛, 小沼宗大, 濱 裕宣, 佐々木 敬, 吉田 博
    • Organizer
      第39回日本臨床栄養学会総会(10月、幕張)
    • Related Report
      2017 Research-status Report
  • [Presentation] SGLT2阻害薬による治療に伴う体組成変化と代謝の連関 LIGHT study2017

    • Author(s)
      佐々木 敬
    • Organizer
      第31回日本臨床内科医学会(10月、大阪)
    • Related Report
      2017 Research-status Report
    • Invited
  • [Presentation] PKCdelta is a key regulator of palmitate-induced beta cell death.2015

    • Author(s)
      Masatsugu Shiozaki ,Kei Fujimoto, Takashi Sasaki, Yoshida K, Kazunori Utsunomiya
    • Organizer
      51st European Association for the Study of Diabetes (EASD) annual meeting
    • Place of Presentation
      Stockholm, Sweden
    • Year and Date
      2015-09-14
    • Related Report
      2015 Research-status Report
    • Int'l Joint Research
  • [Presentation] 教育講演: β細胞におけるインスリン分泌の制御機構2015

    • Author(s)
      佐々木 敬
    • Organizer
      第58回日本糖尿病学会年次学術集会
    • Place of Presentation
      山口
    • Year and Date
      2015-05-21
    • Related Report
      2015 Research-status Report
    • Invited

URL: 

Published: 2014-04-04   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi